Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 67,390,465
- Total 13F value
- $2,011,640,213
- Share change
- +354,235
- Put/Call ratio
- 64%
- SEC-reported price per share
- $29.85
- Number of holders
- 153
- Value change
- +$5,551,590
- Number of buys
- 81
- Number of sells
- 79
- Shares outstanding
- 82,930,729
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
153
Top holders
10
KYMR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Ownership snapshot
Top reported holders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Atlas Venture Fund X, L.P.
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $254,548,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $254.55M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value
Top 5
Atlas Venture Fund X, L.P.
$235.83M
ATLAS VENTURE ASSOCIATES X, L.P.
$173.16M
PRICE T ROWE ASSOCIATES INC /MD/
$254.55M
BAKER BROS. ADVISORS LP
$241.04M
Atlas Venture Life Science Adviso...
$216.17M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Atlas Venture Fund X, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$235,830,130
5,504,905 shares
|
— | 11 Mar 2024 |
| ATLAS VENTURE ASSOCIATES X, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$173,161,222
5,763,012 shares
|
— | 11 Aug 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
denominator unverified
|
$254,548,000
6,332,012 shares
|
— | 31 Mar 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$241,036,306
5,995,928 shares
|
— | 31 Mar 2024 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$216,169,952
5,377,362 shares
|
— | 31 Mar 2024 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$207,504,400
5,161,801 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
153
Shares
67,390,465
Rows available
153
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
161
Q2 2024 holders
153
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend